Tatva Chintan Pharma Chem Ltd
Q1 FY27, unaudited
- Revenue
- ₹146.70 Cr
- Profit after tax
- ₹10.45 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 146.70 | +34.37% | 496.30 |
| Other income | 4.03 | +194.59% | 3.53 |
| Total income | 150.74 | +36.35% | 499.82 |
| Employee benefit expense | 16.74 | +18.81% | 62.93 |
| Finance costs | 2.08 | +403.87% | 2.85 |
| Depreciation & amortisation | 10.57 | +17.79% | 36.84 |
| Total expenses | 135.32 | +30.75% | 446.66 |
| Profit before tax | 14.09 | +99.80% | 53.17 |
| Tax expense | 3.65 | +89.90% | 14.08 |
| Profit after tax | 10.45 | +103.51% | 39.08 |
| Total comprehensive income | 10.49 | +107.23% | 39.26 |
| Earnings per share, basic | ₹4.47 | ₹16.71 |
|---|---|---|
| Earnings per share, diluted | ₹4.47 | ₹16.71 |
Earnings call
Q1 FY27Tatva Chintan reported Q1 FY27 operating revenue of INR1,671 million, up 43% year-on-year and 25% sequentially, with EBITDA of INR323 million, up 86% year-on-year. Management highlighted growth across Phase Transfer Catalysts, Pharma & Agro Intermediates, and Structure Directing Agents segments, along with the first commercial-scale semiconductor product batch being qualified by a customer. The Board approved a new greenfield manufacturing facility involving an investment of approximately INR200 crores.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Earlier calls: Q4 FY26 · All quarters
Filings
12 shown · 40 published by the exchange
19 Aug 2026
Filing18 Aug 2026
Filing11 Aug 2026
07 Aug 2026
ConcallAnalyst / Investor Meet - Intimation
Appears 2 times in the recent filings shown; listed once.
03 Aug 2026
31 Jul 2026
24 Jul 2026
ConcallAnalyst / Investor Meet - Intimation
Appears 3 times in the recent filings shown; listed once.
22 Jul 2026
21 Jul 2026
Transcript21 Jul 2026
20 Jul 2026
18 Jul 2026
Filing
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 19 Aug 2026.